23290-55-3 Usage
Uses
Used in Organic Material Synthesis:
2-t-Butoxythiophene is used as a key building block in the synthesis of organic materials such as polymers, liquid crystals, and organic electronics. Its unique properties contribute to the development of advanced materials with enhanced performance characteristics.
Used in Electronic Applications:
In the Electronics Industry, 2-t-Butoxythiophene is utilized as a component in the creation of electronic devices due to its electrical conductivity, which is essential for their functionality.
Used in Dye and Pigment Production:
2-t-Butoxythiophene is used as a building block in the production of dyes and pigments, where its chemical structure contributes to the color and stability of these products.
Used in Pharmaceutical Research:
In the Pharmaceutical Industry, 2-t-Butoxythiophene is being studied for its potential biological activities, indicating its use as a precursor in the development of new drugs. Its exploration in this field is driven by the search for novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 23290-55-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,2,9 and 0 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 23290-55:
(7*2)+(6*3)+(5*2)+(4*9)+(3*0)+(2*5)+(1*5)=93
93 % 10 = 3
So 23290-55-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H12OS/c1-8(2,3)9-7-5-4-6-10-7/h4-6H,1-3H3
23290-55-3Relevant academic research and scientific papers
Brimble, Margaret A.,Laita, Olivia,Robinson, James E.
, p. 3021 - 3027 (2006)
The uncatalyzed reaction of 2-tert-butyldimethylsilyloxythiophene 2 with 1,4-quinones bearing either an electron withdrawing acetyl or a carbomethoxy group at C-2, was investigated. No reaction was observed using 1,4-quinones 8 and 9 bearing an ester grou
THIENYL BENZOTHIENYL AND DIBENZOTHIENYL COMPOUNDS AS INHIBITORS OF ALDOSE REDUCTASE
-
, (2008/06/13)
The invention concerns heterocyclic nitromethane derivatives of the formula 1 as defined hereinafter (and their non-toxic salts) wherein the heterocyclic moiety Q is thienyl, benzothienyl or dibenzothienyl and may bear a wide variety of optional substituents, together with pharmaceutical compositions containing them. The nitromethane derivatives are inhibitors of the enzyme aldose reductase and are of value in the treatment of certain complications of diabetes and galactosemia
